These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6340700)

  • 21. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris.
    Magder S; Sami M; Ripley R; Lisbona R
    Am J Cardiol; 1987 Jun; 59(15):1289-94. PubMed ID: 3591681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical, cardio- and hemodynamic effects of long- and short-acting beta-adrenergic blockers in the treatment of patients with stable stenocardia].
    Ol'binskaia LI; Bragina GI
    Kardiologiia; 1984 Apr; 24(4):9-13. PubMed ID: 6727119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD; Sander GE; Roffidal L; Thomas MG; Mersch DP; Moyer RR; Burris JF; Mroczek WJ; Brachfeld J
    Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
    Heikkilä J; Nieminen MS
    Am Heart J; 1982 Aug; 104(2 Pt 2):464-72. PubMed ID: 7102533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 31. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
    Dwyer EM; Pepe AJ; Pinkernell BH
    Am Heart J; 1982 May; 103(5):830-3. PubMed ID: 6803556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris.
    Parker JO
    Am J Cardiol; 1983 Apr; 51(7):1062-6. PubMed ID: 6404149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacodynamics of carteolol].
    Odenthal KP
    Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
    Holmes D; Fryda-Kaurimsky Z; Krueger K
    Cardiology; 1990; 77(6):459-65. PubMed ID: 1981493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmaceutical chemical and analytical data for the pharmaceutically-active substance carteolol hydrochloride].
    Winkler W
    Arzneimittelforschung; 1983; 33(2a):279-80. PubMed ID: 6682318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects.
    Velasquez MT; Byrne D; Hoffmann RG
    J Clin Pharmacol; 1985; 25(8):601-6. PubMed ID: 3908501
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.